CATALOGO DEI PRODOTTI DELLA RICERCA

FERDEGHINI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.521
EU - Europa 6.423
AS - Asia 5.603
SA - Sud America 639
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 53
OC - Oceania 15
Totale 24.339
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.374
SG - Singapore 2.606
RU - Federazione Russa 2.139
CN - Cina 1.454
GB - Regno Unito 1.377
BR - Brasile 488
IT - Italia 479
FI - Finlandia 466
HK - Hong Kong 466
FR - Francia 465
DE - Germania 458
VN - Vietnam 423
IE - Irlanda 346
SE - Svezia 318
KR - Corea 193
UA - Ucraina 173
BD - Bangladesh 165
CA - Canada 75
IN - India 65
AR - Argentina 47
TR - Turchia 40
MX - Messico 35
ES - Italia 34
EC - Ecuador 29
JP - Giappone 27
IQ - Iraq 26
BE - Belgio 24
CO - Colombia 24
PL - Polonia 24
ID - Indonesia 23
NL - Olanda 22
ZA - Sudafrica 22
NG - Nigeria 21
AT - Austria 19
PK - Pakistan 17
VE - Venezuela 17
AU - Australia 12
CL - Cile 12
AE - Emirati Arabi Uniti 11
EG - Egitto 10
MA - Marocco 10
EE - Estonia 9
NP - Nepal 9
MY - Malesia 8
PS - Palestinian Territory 8
PY - Paraguay 8
RO - Romania 8
SA - Arabia Saudita 8
DK - Danimarca 7
GT - Guatemala 7
KE - Kenya 7
PH - Filippine 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
EU - Europa 6
JM - Giamaica 6
KZ - Kazakistan 6
LT - Lituania 6
PE - Perù 6
TH - Thailandia 6
HR - Croazia 5
UY - Uruguay 5
AL - Albania 4
AZ - Azerbaigian 4
BG - Bulgaria 4
HU - Ungheria 4
JO - Giordania 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IL - Israele 3
TT - Trinidad e Tobago 3
AI - Anguilla 2
BB - Barbados 2
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DZ - Algeria 2
LB - Libano 2
LI - Liechtenstein 2
LU - Lussemburgo 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
Totale 24.268
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.641
Singapore 1.526
Ashburn 1.434
Southend 1.106
Chandler 1.036
Woodbridge 844
San Jose 843
Dallas 598
Ann Arbor 589
Moscow 586
Hong Kong 459
Houston 418
Dublin 342
The Dalles 328
Verona 232
Council Bluffs 219
Wilmington 194
Lawrence 184
Princeton 184
Beijing 151
Los Angeles 149
New York 147
Nanjing 143
Ho Chi Minh City 140
Sindelfingen 131
Annandale 111
Boardman 111
Buffalo 105
Helsinki 94
Jinan 90
Shenyang 88
Hebei 85
Santa Clara 85
Hanoi 81
Tianjin 70
Philadelphia 63
Changsha 56
Milan 55
Detroit 47
São Paulo 47
Nanchang 46
Columbus 43
Hangzhou 42
Chicago 41
Zhengzhou 41
Haikou 37
Jiaxing 37
Dong Ket 36
Norwalk 35
Ningbo 34
Munich 33
Guangzhou 30
Toronto 27
Las Vegas 26
Washington 26
Orem 25
Redondo Beach 25
Brussels 24
Falls Church 24
Tokyo 23
Bologna 22
Taizhou 22
San Francisco 21
Abuja 20
Warsaw 19
Phoenix 18
Auburn Hills 17
Brooklyn 17
Frankfurt am Main 17
Lanzhou 17
Rio de Janeiro 17
Chennai 16
Lancaster 16
Taiyuan 16
Atlanta 15
Dearborn 15
Tappahannock 15
Da Nang 14
Montreal 14
Seattle 14
Shanghai 14
Stockholm 14
Düsseldorf 13
London 13
Providence 13
Rome 13
Turku 13
Bắc Ninh 11
Charlotte 11
Haiphong 11
Manchester 11
Vienna 11
Amsterdam 10
Biên Hòa 10
Boston 10
Johannesburg 10
Mexico City 10
Redwood City 10
Baghdad 9
Cairo 9
Totale 16.035
Salva come PNG Salva come JPEG
Nome #
[111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas 275
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 257
SU-E-J-168: 4D-PET for Target Volume Delineation in Respiratory-Gated Radiation Therapy. 225
Gated reconstruction in 18FDG PET-CT quantitative imaging: impact on SUV estimation in lung tumors 221
Humanization of care in pediatrics and built-in psychological support in nuclear medicine [Umanizzazione delle cure in età pediatrica e assistenza psicologica integrata in Medicina nucleare] 220
A mathematical model of thyroid mass reduction after radioiodine therapy of Graves’ disease 219
First human Cerenkography. 215
Espressione di Claudina-1 e 7 nel carcinoma papillare della tiroide con comportamento clinico aggressivo 209
External quality control survey for alpha-fetoprotein assay 207
Role of dual-point FDG PET/CT in prone position and fused PET/MR; correlation with biologic prognostic parameters in breast cancer 198
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. 197
rhTSH-Stimulated Postsurgical Thyroid Remnant Ablation in Differentiated Thyroid Cancer: 1.85 vs 3.7 GBq I-131 Activity 194
Valutazione comparativa dell'acquisizione volumetrica tiroidea con ecografia convenzionale B-Mode (US) ed ecografia volumetrica (VUS) 192
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 192
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma 189
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 188
A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma 187
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathology 187
Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal. 186
A new luminescence immunoassay for thyrotropin using coated tubes: evaluation and comparison with immunoradiometric assay 185
Acute suppression of parathyroid activity during hemofiltration 182
RET mutation and increased angiogenesis in medullary thyroid carcinomas 181
[Primary empty sella syndrome. Clinical and radiological study, and evaluation of pituitary function] 179
Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa. 174
A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions 173
Age and Gender Substantially Influence the Relationship Between Thyroid Status and the Lipoprotein Profile: Results from a Large Cross-Sectional Study. 172
Analytical and clinical assessment of a commercial kit for the simultaneous determination of free thyroxine and thyrotropin 170
Optimized PET Imaging for 4D Treatment Planning in Radiotherapy: the Virtual 4D PET Strategy 170
Serum interleukin-6 levels in uterine malignancies. Preliminary data 166
A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours 165
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal. 165
[Bromocriptine therapy from the 2d month of pregnancy induces regression of neuro-ophthalmologic complications caused by macroprolactimona] 164
Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix 163
[Growth factors and oncogenes in development and carcinogenesis. Role of the epidermal growth factor system] 163
[Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer] 156
Comparison of plasma and urinary methods for the direct measurement of the thyroxine to 3,5,3' - triiodothyronine conversion rate in man 155
CAM26, CAM29 and mucin-like carcinoma associated antigen in epithelial ovarian cancer 153
[Tumor markers: new prospects in the diagnosis and clinical monitoring of malignant epithelial neoplasms of the ovary] 151
Clinical validation of the new ELSA-CA 125 II assay: report of a European multicentre evaluation 150
Relation of fetal growth to maternal responses to oral glucose tolerance test throughout gestation 150
A computer program for customized recommendations to radioiodine-treated patients [Studio e realizzazione di un programma computerizzato per prescrizioni personalizzate a pazienti iodiotrattati in dimissione] 148
Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between rhTSH stimulation and prolonged levothyroxine withdrawal. 148
Autonomous thyroid nodule and percutaneous ethanol injection [letter] [see comments] 146
Functional Imaging and Peptide Receptor Radionuclide Therapy 146
Determination of serum levels of different cytokeratins in patients with uterine malignancies 145
Blood markers of early and late airway responses to allergen in asthmatic subjects. Relationship with functional findings 144
Lazaroid U-74389F attenuates phorbol ester-induced lung injury in rabbits 144
Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer 144
Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues. 143
Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty 142
Comparison of tumor-associated trypsin inhibitor (TATI) with CA125 as a marker for diagnosis and monitoring of epithelial ovarian cancer 140
[Comparison of serum determinations of CA125, CA15-3 and CA50 in the preoperative evaluation of adnexal tumors] 140
Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis. 140
The relationship between maternal relaxation and plasma beta-endorphin levels during parturition 139
Percutaneous ethanol injection treatment of autonomous thyroid adenoma: hormonal and clinical evaluation [see comments] 139
Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancer 139
[Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary] 138
Plasma leptin levels in newborns from normal and diabetic mothers. 138
Anticlastogenic Effect of Ginkgo biloba Extract in Graves' Disease Patients Receiving Radioiodine Therapy 138
CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancer 137
Tumor-associated trypsin inhibitor (TATI) and renal function 137
Serum tumour-associated trypsin inhibitor (TATI) and renal function 137
Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma 136
The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients 134
Radioimmunoassay of unconjugated and total serum estetrol using a 125I-iodinated tracer 134
Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses 133
T-helper 1 and 2 activation with fresh or cultured allo- or xenoislets 133
Comparison between serum CA 125 and CA 19-9 assays and tissular OC 125 and 1116NS 19-9 reactivity in malignant and benign ovarian tumors 132
Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid). 132
Effect of anabolic treatment on the serum levels of gonadotropins, testosterone, prolactin, thyroid hormones and myoglobin of male athletes under physical training 131
Preoperative serum intercellular adhesion molecule-1 (ICAM-1) and E-selectin (endothelial cell leukocyte adhesion molecule, ELAM-1) in patients with epithelial ovarian cancer 129
Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia 129
Can insulin action induce myocardial texture alterations in essential hypertension? 129
Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders 128
Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer 128
Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialytic renal failure 128
Comet assay on children's leukocytes 8 years after the Chernobyl disaster 127
The trend of serum CA125 levels during the first three courses of chemotherapy as a predictor of second-look findings in patients with ovarian carcinoma 127
Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer. 127
Preoperative serum E-cadherin assay in patients with ovarian carcinoma 126
The measurement of plasma D-dimer (DD) levels in the follow-up of patients with ovarian cancer 126
Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations 126
Serum soluble interleukin-2 receptor assay in epithelial ovarian cancer 126
Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma 126
Hypothalamo-pituitary function in four cases of true precocious puberty 126
Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine? 126
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis 125
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer 125
Effects of the ablation of the submaxillary gland on the rat testis 125
Relationship between the circulating levels of adenohypophyseal hormones in blood and in cerebrospinal fluid 125
High-performance liquid chromatographic separation of iodoamino acids for tracer turnover studies of thyroid hormones in vivo 125
External quality assurance of the carcinoembryonic antigen (CEA) assay: main findings in six years' experience 124
Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma 124
Anomalous between-laboratory variability in a collaborative study of carcinoembryonic antigen immunoassay [letter] 124
Assessment of tumor-associated trypsin inhibitor (TATI) as a marker of renal function. 124
Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome. 124
Role of serum carrier proteins in the peripheral metabolism and tissue distribution of thyroid hormones in familial dysalbuminemic hyperthyroxinemia and congenital elevation of thyroxine-binding globulin 123
Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects. 123
Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women 122
Human placental lactogen (hPL) deficiency in a normal pregnancy 122
Totale 15.391
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.062
article - articoli 79.932
book - libri 0
conference - conferenze 2.818
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.312
Totale 168.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022789 0 0 0 37 35 24 13 81 81 49 127 342
2022/20232.784 228 176 256 505 351 599 15 238 274 17 85 40
2023/20241.097 79 143 109 257 86 136 24 35 7 13 115 93
2024/20252.780 250 192 31 497 158 39 30 165 506 168 228 516
2025/20268.550 683 459 659 1.060 1.819 550 1.160 528 694 477 218 243
2026/20271.362 178 255 445 484 0 0 0 0 0 0 0 0
Totale 24.339